| Literature DB >> 32670196 |
Rachel Natovich1,2, Noa Gayus1, Michal Azmon3, Hila Michal1, Omri Gury Twito1,2, Tomer Yair1, Svetlana Raudoi1, Ori Kapra1, Tali Cukierman-Yaffe1,4.
Abstract
Background: Older people with diabetes have an increased risk for disability and cognitive dysfunction, which may impede self-care capacity. These are not evaluated routinely in current health systems. In the Center for Successful Aging with Diabetes, patients over the age of 60 undergo multi-disciplinary evaluation days and are provided with an integrated (cognitive, physical, nutritional, and medical) treatment plan. Among individuals with below-normal cognitive function, self-adherence to these recommendations poses a challenge. Thus, the aim of this study was to test the feasibility of a multidisciplinary intervention amongst older people with diabetes with below-normal cognitive function and sub-optimal glucose control.Entities:
Keywords: A1C; aging; cognition; diabetes; intervention
Mesh:
Year: 2020 PMID: 32670196 PMCID: PMC7326129 DOI: 10.3389/fendo.2020.00348
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1Schematic description of the complex multi-disciplinary intervention. The intervention consisted of a two-arm intervention: (A) a medical intervention: monthly meetings with a diabetes nurse-educator, supervised by a diabetes specialist and study psychologist during which changes in their pharmacological regimen of glucose, blood pressure, and lipid control were made, and (B) a cognitive/physical rehabilitation intervention. This arm consisted of (1) an intensive phase-group meetings which included computerized cognitive training, aerobic, balance, and strength exercise, and group discussions and (2) a monthly consolidation phase.
Demographic & medical characteristics.
| Age | 73 (4) |
| Female | 38 (8) |
| Education | 14 (4) |
| Smoking | 14 (3) |
| Dyslipidemia | 71 (15) |
| HTN | 76 (16) |
| Diabetes duration(Y) | 19 (9) |
| A1C(%) | 8.8 (0.99) |
| Experienced severe hypoglycemia | 14 (3) |
| Neuropathy | 43 (9) |
| Retinopathy | 5 (1) |
| Nephropathy | 38 (8) |
| IHD | 43 (9) |
| CVD | 24 (5) |
| Insulin user | 76 (16) |
| Statin use | 71 (15) |
Baseline Cognitive, Psycho-Social, Self-care Characteristics.
| PHQ-9 | 4.6 (3.9) | 4 (2, 6) |
| MOCA | 22.7 (2.8) | 24 (20, 25) |
| DSST | 8.1 (1.9) | 8 (7, 9) |
| VF phonetic | −0.51 (1.3) | −0.5 (−1.3, 0.5) |
| VF semantic | −0.55 (1) | −0.54 (−1.1, 0.04) |
| Neurotrax global cognitive score | 95.8 (5.7) | 95 (92.4, 99) |
| Neurotrax memory score | 97 (13.3) | 97 (88.3, 107.2) |
| Neurotrax executive function score | 93.3 (8.6) | 96 (90.1, 101.9) |
| Neurotrax attention score | 93.7 (11.9) | 97.3 (83.5, 102.6) |
| Neurotrax motor skills | 97.1 (6.5) | 96.6 (92.1, 101.8) |
| SDSCA diet score | 4.06 (1.05) | 4.2 (3.43, 4.9) |
| SDSCA exercise score | 1.17 (1.09) | 1 (0, 2) |
| SDSCA blood glucose testing | 5.1 (2.7) | 7 (4.5, 7) |
| SDSCA adherence to medication | 7 (0) | 7 (0) |
| SDSCA foot care | 3.9 (1.9) | 4.2 (2.6, 5.4) |
Patient Health Questionnaire (PHQ-9) for depression symptom assessment (.
Figure 2Median (IQR) baseline, 3 month & change (p for comparison) in A1C, quality of life, & physical indices. (A) A1C (%); (B) WHO-5 well-being questionnaire (26); (C) single general self- rated health question (27); (D) grip strength(kg) assessed using a Jammer dynamometer (25); (E) 30-s chair stand, score is the number of stands in 30 s (24); (F) 6-min walk distance (meters) (14–16); (G) 10-meter walk (seconds) (17, 18); (H) Four Step Square Test (FSST) (seconds) (19); (I) timed Up & Go (TUG) (seconds) (20–23).
Change in A1C, physical indices, and quality of life after 3 & 12 months.
| A1C | −0.16 (0.21) | −0.56 (0.23) | −0.72 (0.23) |
| WHO | 0.24 (1.23) | −0.16 (1.31) | 0.08 (1.30) |
| Health question | −5.32 (3.50) | 4.24 (3.80) | −1.08 (3.78) |
| Grip Strength (kg) | 0.08 (0.65) | −4.19(0.70) | −4.11(0.70) |
| 30-s chair stand | 2.27 (0.75) | −0.22 (0.83) | 2.10 (0.83) |
| 6-min walk (meters) | 39.13 (12.73) | 23.70 (13.97) | 62.84 (13.94) |
| 10-meter walk (seconds) | −0.40 (0.39) | 0.19 (0.43) | −0.21 (0.43) |
| FSST (seconds) | −2.30 (0.49) | 0.67 (0.53) | −1.62 (0.53) |
| TUG (seconds) | −1.40 (0.55) | 1.91 (0.60) | 0.52 (0.60) |
p < 0.05; scores presented are follow-up minus baseline- mean (SE); WHO-5 well-being questionnaire (.